---
title: "Long-term changes in mortality and inverse pandemic/post‑pandemic excess death patterns"
id: "medrxiv-2-long-term-mortality-rate-changes-and-inverse-patterns-for-pandemic-and-post"
canonical_url: "https://medichelpline.com/clinical-feed/medrxiv-2-long-term-mortality-rate-changes-and-inverse-patterns-for-pandemic-and-post"
content_type: "clinical_feed_article"
specialty: "General"
source_name: "medRxiv (Clinical Preprints)"
source_url: "https://www.medrxiv.org/content/10.64898/2026.08.14.26360482v1?rss=1"
published_at: "2026-08-17T12:00:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Long-term changes in mortality and inverse pandemic/post‑pandemic excess death patterns
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/medrxiv-2-long-term-mortality-rate-changes-and-inverse-patterns-for-pandemic-and-post
- **Specialty:** [General](https://medichelpline.com/clinical-feed/general.md)
- **Primary Source:** medRxiv (Clinical Preprints)
- **Source URL:** [Original Journal Publication](https://www.medrxiv.org/content/10.64898/2026.08.14.26360482v1?rss=1)
- **Published At:** 2026-08-17T12:00:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- The authors analyzed mortality changes and **excess deaths** for 38 populations with reliable death registration using age-stratified data and four baseline models covering 2020–2025. - Four models were used: Fa (mean 2017–2019 baseline), a trend-of-trends model (TTa), a shrinkage variant (STTa), and a shrinkage variant incorporating 2024–2025 data for trend calculation (STTa⁺). - Weighted mean slope of age-stratified mortality rates in 2019 was −0.58% per year; the weighted mean slope-of-slopes was +0.106% per year-squared, indicating heterogeneous long-term trajectories across populations. - On average across models, six populations (Luxembourg, Ireland, Sweden, New Zealand, Denmark, Korea) had cumulative death deficits for 2020–2025; six others (Chile, Bulgaria, Japan, Greece, USA, Italy) had >4% cumulative excess deaths. - Differences between populations were larger in 2020–2023; however, 33 of 38 countries had estimated death deficits in 2024–2025, indicating a post‑pandemic reversal in many settings. - Aggregate excess deaths for 2020–2025 ranged from 1.16 to 2.63 million; broken down, 2020–2023 excess deaths were 2.19–3.03 million, while 2024–2025 showed a net deficit of −1.03 to −0.40 million. - The authors highlight that failure to apply **age stratification** and use of unchanged linear trends for baselines can substantially upward-bias excess death estimates. - Socioeconomically more vulnerable populations experienced higher pandemic mortality but a more pronounced post‑pandemic death deficit, which the authors note may reflect earlier deaths of people with modest remaining life expectancy during the pandemic. - All processed age-stratified data and analysis code reproducing figures and tables are available in a public repository; raw mortality inputs come from the Human Mortality Database, Eurostat, and national statistical offices. - The paper emphasizes careful consideration of changing population age structure and long-term mortality trajectories when estimating **excess deaths**, and documents heterogeneous, sometimes inverse, pandemic versus post‑pandemic patterns.
## Clinical Analysis & Structured Key Points
[](https://www.medrxiv.org/cdn-cgi/content?id=pZZgwMZ4U5JUqXmnhyfm72kgNC8VNqntu1h1x603Qkk-1786990957.2421076-1.2.1.1-8zeeSRpVUTAvXaCo4E6o0iSHHjoAmr1UT57IZ7VxFTRxm6nkbPHFroZjaHr5pfd8) [Skip to main content](https://www.medrxiv.org/content/10.64898/2026.08.14.26360482v1?rss=1#main-content) [![medRxiv](https://www.medrxiv.org/sites/default/files/medrxiv_inner_logo.png)](https://www.medrxiv.org/) * [Home](https://www.medrxiv.org/) * [Submit](https://www.medrxiv.org/submit-a-manuscript) * [FAQ](https://www.medrxiv.org/about/FAQ) * [Blog](https://connect.medrxiv.org/news/) * [ALERTS / RSS](https://www.medrxiv.org/content/alertsrss) * [Resources](https://connect.medrxiv.org/resources/) * [About](https://www.medrxiv.org/content/about-medrxiv) Search for this keyword [Advanced Search](https://www.medrxiv.org/search) Follow this preprint # Long-term mortality rate changes and inverse patterns for pandemic and post-pandemic excess mortality [ View ORCID Profile](http://orcid.org/0000-0003-3118-6859)John Ioannidis, [ View ORCID Profile](http://orcid.org/0000-0002-8414-7397)Michael Levitt doi: https://doi.org/10.64898/2026.08.14.26360482 [This article is a preprint and has not been certified by peer review [](https://www.medrxiv.org/about/FAQ#unrefereed)[what does this mean?](https://www.medrxiv.org/about/FAQ#unrefereed)]. It reports new medical research that has yet to be evaluated and so should _not_ be used to guide clinical practice. John Ioannidis Stanford University School of Medicine * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=John%2BIoannidis%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Ioannidis%20J&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AJohn%2BIoannidis%2B) * [ORCID record for John Ioannidis](http://orcid.org/0000-0003-3118-6859 "Open in new tab") Michael Levitt Stanford University School of Medicine * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Michael%2BLevitt%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Levitt%20M&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AMichael%2BLevitt%2B) * [ORCID record for Michael Levitt](http://orcid.org/0000-0002-8414-7397 "Open in new tab") * For correspondence: michael.levitt@stanford.edu * [Abstract](https://www.medrxiv.org/content/10.64898/2026.08.14.26360482v1)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_art/node:1280199/1) * [Info/History](https://www.medrxiv.org/content/10.64898/2026.08.14.26360482v1.article-info)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_info/node:1280199/1) * [Metrics](https://www.medrxiv.org/content/10.64898/2026.08.14.26360482v1.article-metrics)[](https://www.medrxiv.org/panels_ajax_tab/article_tab_metrics/node:1280199/1) * [Data/Code](https://www.medrxiv.org/content/10.64898/2026.08.14.26360482v1.external-links)[](https://www.medrxiv.org/panels_ajax_tab/article_tab_data_code/node:1280199/1) * [ Preview PDF](https://www.medrxiv.org/content/10.64898/2026.08.14.26360482v1.full.pdf+html)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_pdf/node:1280199/1) ![Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif) ## Abstract The COVID-19 pandemic and pandemic response may have long-term consequences. The cumulative impact may be better appraised when post-pandemic years are also considered. For 38 populations with reliable death registration data, we estimated excess deaths for 2020-2025 with 4 models and granular age stratification. The Fa model compared deaths against the mean of 2017-2019. Three other trend models considered changes in mortality rates after 2003 (or after a country reached $20,000 per capita income) factoring trend-of-trends (TTa), including shrinkage (STTa), and factoring also the 2024-2025 data for trend-of-trends calculation (STTa⁺). Slopes (weighted mean -0.58%/year in 2019) and slopes-of-slopes (weighted mean +0.106%/year-squared) for age-stratified mortality rates were highly heterogeneous across populations. On model average, 6 populations (Luxembourg, Ireland, Sweden, New Zealand, Denmark, Korea) had cumulative death deficits during 2020-2025, while another 6 (Chile, Bulgaria, Japan, Greece, USA, Italy) had >4% excess deaths. Differences across populations were more prominent during 2020-2023, while 33/38 countries had estimated death deficits in 2024-2025. Total 2020-2025 excess deaths were 1.16-2.63 million (2020-2023: 2.19-3.03 million; 2024-2025: -1.03 to -0.40 million deficit). Lack of age stratification and use of unchanged linear trends for the baseline grossly biased excess death estimates upwards. Socioeconomically more vulnerable populations had higher pandemic deaths, but a more pronounced post-pandemic death deficit. Excess death estimates require careful consideration of changing population age structure and long-term mortality trajectories. Post-pandemic death deficits, especially in more vulnerable populations, may reflect deaths of people with modest life expectancy during the pandemic with respective pay off in 2024-2025 ### Competing Interest Statement The authors have declared no competing interest. ### Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable. Yes ## Data Availability Data and code availability: All analysis code and the processed age-stratified dataset (annual deaths and mid-year populations by twenty five-year age bands for the 38 populations) that reproduce every figure and table in this paper are openly available at https://github.com/michaellevitt/BaselinePaper-repro. Raw mortality data are not redistributed: they are available from the Human Mortality Database (www.mortality.org, free registration required), Eurostat, and the national statistical offices listed in the repository documentation and in SI Methods 1. ## Funder Information Declared National Institutes of Health, https://ror.org/01cwqze88, R35 GM122543, R01ES032470 Office of Naval Research, N000142412687 Copyright The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a [CC-BY-NC-ND 4.0 International license](http://creativecommons.org/licenses/by-nc-nd/4.0/). bioRxiv and medRxiv thank the following for their generous financial support: > The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, The University of Edinburgh, University of Washington, and Vrije Universiteit Amsterdam. [Donate to openRxiv ](https://www.zeffy.com/en-US/donation-form/donate-to-make-a-difference-10981) [ Back to top](https://www.medrxiv.org/content/10.64898/2026.08.14.26360482v1?rss=1#page) [ Previous](https://www.medrxiv.org/content/10.64898/2026.08.15.26359980v1 "Integrating respiratory infection surveillance and temperature data improves all-season mortality reconstruction") Posted August 17, 2026. [ Download PDF](https://www.medrxiv.org/content/10.64898/2026.08.14.26360482v1.full.pdf) Print/Save Options [Download PDF](https://www.medrxiv.org/content/medrxiv/early/2026/08/17/2026.08.14.26360482.full.pdf)Full Text & In-line FiguresXML [More Info](https://www.medrxiv.org/about/FAQ#PrintOptions "More Information on Print/Save Options") [ Author Declarations](https://www.medrxiv.org/content/10.64898/2026.08.14.26360482v1#p-5) [ Data/Code](https://www.medrxiv.org/content/early/2026/08/17/2026.08.14.26360482.external-links) [ Email](https://www.medrxiv.org/ "Email this Article") [ Share](https://www.medrxiv.org/) Long-term mortality rate changes and inverse patterns for pandemic and post-pandemic excess mortality John Ioannidis, Michael Levitt medRxiv 2026.08.14.26360482; doi: https://doi.org/10.64898/2026.08.14.26360482 [This article is a preprint and has not been certified by peer review [](https://www.medrxiv.org/about/FAQ#unrefereed)[what does this mean?](https://www.medrxiv.org/about/FAQ#unrefereed)]. It reports new medical research that has yet to be evaluated and so should _not_ be used to guide clinical practice. Share This Article: Copy [![Twitter logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/twitter.png)](https://www.medrxiv.org/highwire_log/share/twitter?link=http%3A%2F%2Ftwitter.com%2Fshare%3Furl%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.08.14.26360482v1%26text%3DLong-term%2520mortality%2520rate%2520changes%2520and%2520inverse%2520patterns%2520for%2520pandemic%2520and%2520post-pandemic%2520excess%2520mortality "Share this on Twitter") [![Facebook logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/fb-blue.png)](https://www.medrxiv.org/highwire_log/share/facebook?link=http%3A%2F%2Fwww.facebook.com%2Fsharer.php%3Fu%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.08.14.26360482v1%26t%3DLong-term%2520mortality%2520rate%2520changes%2520and%2520inverse%2520patterns%2520for%2520pandemic%2520and%2520post-pandemic%2520excess%2520mortality "Share on Facebook") [![LinkedIn logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/linkedin-32px.png)](https://www.medrxiv.org/highwire_log/share/linkedin?link=http%3A%2F%2Fwww.linkedin.com%2FshareArticle%3Fmini%3Dtrue%26url%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.08.14.26360482v1%26title%3DLong-term%2520mortality%2520rate%2520changes%2520and%2520inverse%2520patterns%2520for%2520pandemic%2520and%2520post-pandemic%2520excess%2520mortality%26summary%3D%26source%3DmedRxiv "Publish this post to LinkedIn") [![Mendeley logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/mendeley.png)](https://www.medrxiv.org/highwire_log/share/mendeley?link=http%3A%2F%2Fwww.mendeley.com%2Fimport%2F%3Furl%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.08.14.26360482v1%26title%3DLong-term%2520mortality%2520rate%2520changes%2520and%2520inverse%2520patterns%2520for%2520pandemic%2520and%2520post-pandemic%2520excess%2520mortality "Share on Mendeley") [ Citation Tools](https://www.medrxiv.org/ "Citation Tools") [ Get QR code](https://connect.medrxiv.org/qr/2026.08.14.26360482) * [Tweet Widget](http://twitter.com/share?url=https%3A//www.medrxiv.org/content/10.64898/2026.08.14.26360482v1&count=horizontal&via=&text=Long-term%20mortality%20rate%20changes%20and%20inverse%20patterns%20for%20pandemic%20and%20post-pandemic%20excess%20mortality&counturl=www.medrxiv.org/content/10.64898/2026.08.14.26360482v1 "Tweet This") Reviews and Context 0 Comment 0 TRIP Peer Reviews 0 Community Reviews 0 Automated Services 0 Blogs/Media 0 Author Videos **Subject Areas** [**All Articles**](https://www.medrxiv.org/content/early/recent) * [Addiction Medicine](https://www.medrxiv.org/collection/addiction-medicine) (605) * [Allergy and Immunology](https://www.medrxiv.org/collection/allergy-and-immunology) (891) * [Anesthesia](https://www.medrxiv.org/collection/anesthesia) (324) * [Cardiovascular Medicine](https://www.medrxiv.org/collection/cardiovascular-medicine) (4719) * [Dentistry and Oral Medicine](https://www.medrxiv.org/collection/dentistry-and-oral-medicine) (471) * [Dermatology](https://www.medrxiv.org/collection/dermatology) (403) * [Emergency Medicine](https://www.medrxiv.org/collection/emergency-medicine) (633) * [Endocrinology (including Diabetes Mellitus and Metabolic Disease)](https://www.medrxiv.org/collection/endocrinology-including-diabetes-mellitus-and-metabolic-disease) (1602) * [Epidemiology](https://www.medrxiv.org/collection/epidemiology) (15731) * [Forensic Medicine](https://www.medrxiv.org/collection/forensic-medicine) (32) * [Gastroenterology](https://www.medrxiv.org/collection/gastroenterology) (1189) * [Genetic and Genomic Medicine](https://www.medrxiv.org/collection/genetic-and-genomic-medicine) (6927) * [Geriatric Medicine](https://www.medrxiv.org/collection/geriatric-medicine) (723) * [Health Economics](https://www.medrxiv.org/collection/health-economics) (1043) * [Health Informatics](https://www.medrxiv.org/collection/health-informatics) (4913) * [Health Policy](https://www.medrxiv.org/collection/health-policy) (1416) * [Health Systems and Quality Improvement](https://www.medrxiv.org/collection/health-systems-and-quality-improvement) (1718) * [Hematology](https://www.medrxiv.org/collection/hematology) (571) * [HIV/AIDS](https://www.medrxiv.org/collection/hiv-aids) (1319) * [Infectious Diseases (except HIV/AIDS)](https://www.medrxiv.org/collection/infectious_diseases) (16194) * [Intensive Care and Critical Care Medicine](https://www.medrxiv.org/collection/intensive-care-and-critical-care-medicine) (1152) * [Medical Education](https://www.medrxiv.org/collection/medical-education) (657) * [Medical Ethics](https://www.medrxiv.org/collection/medical-ethics) (150) * [Nephrology](https://www.medrxiv.org/collection/nephrology) (713) * [Neurology](https://www.medrxiv.org/collection/neurology) (7101) * [Nursing](https://www.medrxiv.org/collection/nursing) (358) * [Nutrition](https://www.medrxiv.org/collection/nutrition) (1064) * [Obstetrics and Gynecology](https://www.medrxiv.org/collection/obstetrics-and-gynecology) (1214) * [Occupational and Environmental Health](https://www.medrxiv.org/collection/occupational-and-environmental-health) (990) * [Oncology](https://www.medrxiv.org/collection/oncology) (3539) * [Ophthalmology](https://www.medrxiv.org/collection/ophthalmology) (1024) * [Orthopedics](https://www.medrxiv.org/collection/orthopedics) (384) * [Otolaryngology](https://www.medrxiv.org/collection/otolaryngology) (440) * [Pain Medicine](https://www.medrxiv.org/collection/pain-medicine) (461) * [Palliative Medicine](https://www.medrxiv.org/collection/palliative-medicine) (138) * [Pathology](https://www.medrxiv.org/collection/pathology) (700) * [Pediatrics](https://www.medrxiv.org/collection/pediatrics) (1761) * [Pharmacology and Therapeutics](https://www.medrxiv.org/collection/pharmacology-and-therapeutics) (728) * [Primary Care Research](https://www.medrxiv.org/collection/primary-care-research) (754) * [Psychiatry and Clinical Psychology](https://www.medrxiv.org/collection/psychiatry-and-clinical-psychology) (5775) * [Public and Global Health](https://www.medrxiv.org/collection/public-and-global-health) (9607) * [Radiology and Imaging](https://www.medrxiv.org/collection/radiology-and-imaging) (2355) * [Rehabilitation Medicine and Physical Therapy](https://www.medrxiv.org/collection/rehabilitation-medicine-and-physical-therapy) (1415) * [Respiratory Medicine](https://www.medrxiv.org/collection/respiratory-medicine) (1231) * [Rheumatology](https://www.medrxiv.org/collection/rheumatology) (631) * [Sexual and Reproductive Health](https://www.medrxiv.org/collection/sexual-and-reproductive-health) (759) * [Sports Medicine](https://www.medrxiv.org/collection/sports-medicine) (571) * [Surgery](https://www.medrxiv.org/collection/surgery) (755) * [Toxicology](https://www.medrxiv.org/collection/toxicology) (106) * [Transplantation](https://www.medrxiv.org/collection/transplantation) (300) * [Urology](https://www.medrxiv.org/collection/urology) (282) Evaluation/discussion of this paper x Comments 0TRiP 0Community 0Automated 0Blogs/Media 0Video 0 Comments medRxiv aims to provide a venue for anyone to comment on a medRxiv preprint. Comments are moderated for offensive or irrelevant content (this can take ~24 h). Please avoid duplicate submissions. The content of a comment is not endorsed by medRxiv. medRxiv is now using a new commenting interface powered by Hypothes.is. All comments previously submitted via the legacy platform (Disqus) have been transferred to the new platform using the medRxiv_admin account. Please read our [commenting guide](https://connect.biorxiv.org/news/2022/03/21/commenting_on_preprints) for more information. Share this comments tab (click to copy link)Copied! TRiP medRxiv partners with journals and review services to enable posting of peer reviews and editorial decisions related to preprints they are evaluating. Reviews are posted with the consent of the authors. TRiP reviews are part of a peer review pilot project in which participating organizations post peer reviews of manuscripts they are evaluating _There is no TRiP material for this paper._ Community Reviews medRxiv aims to inform readers about online discussion of this preprint occurring elsewhere. The content at the links below is not endorsed by either medRxiv or the preprint's authors. Community reviews for this article: _There are no community reviews for this paper._ Automated Evaluations Certain services provide automated analysis of preprints. Analyses invited by the authors are displayed at the top of this tab. Those done independently of authors are shown underneath . None of these analyses is endorsed by medRxiv. Automated Evaluations: _There are no automated evaluations for this paper._ Blog/Media Links medRxiv aims to inform readers about online discussion of this preprint occurring elsewhere. The content at the links below is not endorsed by either medRxiv or the preprint's authors. Video medRxiv partners with conferences and institutions to display recordings of talks and seminars related to preprints. These are posted with the consent of the authors. Video: _There are no videos for this paper._ Powered by [![Hypothes.is logo](https://connect.biorxiv.org/eval/hypothesis.png)](https://web.hypothes.is/) Powered by [![Altmetric logo](https://connect.biorxiv.org/eval/altmetric.png)](https://www.altmetric.com/) ## Follow this preprint X You can now receive automatic notifications when a preprint is revised, withdrawn, commented on, peer reviewed, or published in a journal. Select the events you would like to follow below and click "Submit". To see all of the preprints you are currently following, please go to the [medRxiv Alerts Page](https://medrxiv.org/alerts). Sign In to Follow this Preprint Email * Email this Articleclose Thank you for your interest in spreading the word about medRxiv. NOTE: Your email address is requested solely to identify you as the sender of this article. Your Email * Your Name * Send To * Enter multiple addresses on separate lines or separate them with commas. You are going to
## Related Clinical Research

- [Readers’ reactions: M.D. vs D.O., AI and physician autonomy, surrogacy, postpartum psychiatry, and](https://medichelpline.com/clinical-feed/stat-news-0-opinion-what-stat-readers-think-about-m-d-vs-d-o-ai-in-medicine-surrogacy-and.md)
- [Which interventions affect biological aging? Epigenetic study finds diet, exercise, and some drugs](https://medichelpline.com/clinical-feed/medical-news-today-0-what-can-and-can-t-slow-down-aging-new-study-offers-clues.md)
- [Lindsay Clancy case highlights risks of fragmented U.S. health care and postpartum care gaps](https://medichelpline.com/clinical-feed/stat-news-1-stat-lindsay-clancy-case-exposes-dangers-of-fragmented-u-s-health-system.md)
- [Keto Diet Shows Superior Metabolic Benefits Over Mediterranean and Low-Fat Diets](https://medichelpline.com/clinical-feed/medical-news-today-1-keto-diet-may-have-metabolic-advantages-over-mediterranean-low-fat-diets.md)
- [Neuromuscular Electrical Stimulation of the Common Peroneal Nerve Improves Early Wound Healing and](https://medichelpline.com/clinical-feed/medrxiv-0-sub-analysis-of-a-randomized-controlled-trial-of-neuromuscular.md)

## Navigation
- [← Back to General Feed](https://medichelpline.com/clinical-feed/general.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.